logo

For the Inventor, By the Inventor

Newton, MA, United States of America

Bertal Huseyin Aktas

This inventor holds 5 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent. Top assignee: Harvard College. Active years: 2012-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bertal Huseyin Aktas. Retrieved from https://idiyas.com/inventor/bertal-huseyin-aktas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 80.0


Average Co-Inventor Count = 3.8

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:

goldMedal5 out of 3,078 
 
Harvard College
 patents

Years Active: 2012-2018

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents
1. 9932300 - N,N'-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation (2018-04-03),
2. 9421211 - N,N'-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation (2016-08-23),
3. 8969573 - Compounds for the inhibition of cellular proliferation (2015-03-03),
4. 8354440 - 3-3-di-substituted-oxindoles as inhibitors of translation initiation (2013-01-15),
5. 8257931 - Regulation of protein synthesis (2012-09-04),

Title: Bertal Huseyin Aktas: Innovator in Translation Initiation Inhibitors

Introduction

Bertal Huseyin Aktas is a notable inventor based in Newton, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit translation initiation. With a total of 5 patents, his work has the potential to impact various medical treatments.

Latest Patents

Aktas's latest patents focus on N,N'-diarylurea compounds and N,N'-diarylthiourea compounds as inhibitors of translation initiation. These compositions and methods are designed to treat a range of conditions, including cellular proliferative disorders, non-proliferative degenerative disorders, and viral infections. His innovative approach provides new avenues for therapeutic interventions using these compounds.

Career Highlights

Bertal Huseyin Aktas is affiliated with Harvard College, where he continues to advance his research and development efforts. His work is characterized by a commitment to exploring the biochemical mechanisms that underlie various diseases, thereby contributing to the broader scientific community.

Collaborations

Aktas has collaborated with esteemed colleagues such as José A Halperin and Michael Chorev. These partnerships enhance the scope and impact of his research, fostering an environment of innovation and discovery.

Conclusion

Bertal Huseyin Aktas stands out as a significant figure in the realm of biochemistry, with a focus on translation initiation inhibitors. His contributions through patents and collaborations reflect his dedication to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…